Capitol Hill's recent focus on obesity and GLP-1 medication access highlights rising healthcare costs, affecting both patients and employers. Learn how Calibrate can help.

by Calibrate

Article published on November 1, 2024

science

Transforming Workplace Health: Calibrate Results Demonstrate the Significance of a BMI of <25

by CalibrateNovember 1, 2024

science

Research Recap: GLP-1 Access & Clinical Outcomes for Obesity Treatment

by CalibrateAugust 28, 2024

science

Setting New Standards: The Impact of Clinical Pathways on Obesity Treatment

by Kristin Baier, MDJuly 29, 2024

science

Weight Loss Myths: 6 Biggest Weight Loss Myths, Busted

by CalibrateJuly 27, 2024

science

It’s Not Willpower, It’s Biology

by CalibrateJuly 20, 2024

science

Shaping the Future of Obesity Treatment in Healthcare

by CalibrateApril 29, 2024

science

Weight Loss Motivation: It's More Complicated Than Willpower

by CalibrateMarch 18, 2024

science

Decoding GLP-1 Tapering: Calibrate’s Strategic Approach to Sustainable Health

by Kristin Baier, MDMarch 1, 2024

science

Transforming Obesity Management

by CalibrateFebruary 27, 2024

science

You Hit a Weight Loss Plateau—What Next?

by Sona Shah, MDNovember 17, 2023

1 2

science

Real-World Outcomes from Calibrate’s Employer-Sponsored Obesity Treatment Program

From Bariatric Surgery to GLP-1s: How Obesity Treatment Is Evolving in the Workplace

Is It Possible to Increase GLP-1 Naturally?

Is Obesity a Chronic Disease? Yes—Here's Why That Matters

Virtual Weight Management Programs vs. In-Person Traditional Care: What’s Best for Your Employees?

5 Ways Employee Wellness Programs Like Calibrate’s Metabolic Reset Reduce Healthcare Costs & Improve Productivity

The Role of Behavior Change in Sustainable Health

Why It Takes More Than a Healthy Diet to Lose Weight

Moving Beyond Weight Loss: Calibrate’s Broader Impact on Health Outcomes

What You Should Know About Microdosing Ozempic®

Obesity in the Spotlight on Capitol Hill: What It Means for Employers

Transforming Workplace Health: Calibrate Results Demonstrate the Significance of a BMI of <25

Research Recap: GLP-1 Access & Clinical Outcomes for Obesity Treatment

Setting New Standards: The Impact of Clinical Pathways on Obesity Treatment

Weight Loss Myths: 6 Biggest Weight Loss Myths, Busted

It’s Not Willpower, It’s Biology

Shaping the Future of Obesity Treatment in Healthcare

Weight Loss Motivation: It's More Complicated Than Willpower

Decoding GLP-1 Tapering: Calibrate’s Strategic Approach to Sustainable Health

Transforming Obesity Management

You Hit a Weight Loss Plateau—What Next?

Take the first step today